Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Stock Information for Crescita Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Crescita Therapeutics Inc

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
Crescita Reports Second Quarter 2024 Results
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World's Smallest Intradermal Delivery Device
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
Crescita to Acquire Strategic Assets of Occy Laboratory
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.